Cancer cell adaptation to chemotherapy

Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from experiments with cell lines, as studies in tumor-derived cells are difficult. Studies of human...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC cancer Ročník 5; číslo 1; s. 78
Hlavní autori:	Di Nicolantonio, Federica, Mercer, Stuart J, Knight, Louise A, Gabriel, Francis G, Whitehouse, Pauline A, Sharma, Sanjay, Fernando, Augusta, Glaysher, Sharon, Di Palma, Silvana, Johnson, Penny, Somers, Shaw S, Toh, Simon, Higgins, Bernie, Lamont, Alan, Gulliford, Tim, Hurren, Jeremy, Yiangou, Constantinos, Cree, Ian A
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England BioMed Central 18.07.2005 BMC
Predmet:	Antineoplastic Agents - pharmacology ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism Biopsy Camptothecin - analogs & derivatives Camptothecin - pharmacology Cell Line, Tumor Cisplatin - pharmacology Down-Regulation Doxorubicin - pharmacology Drug Resistance, Neoplasm Drug Therapy - methods Epirubicin - pharmacology Fluorouracil - pharmacology Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Neoplasms - drug therapy Paclitaxel - pharmacology Recurrence Reverse Transcriptase Polymerase Chain Reaction Time Factors Topotecan - pharmacology Treatment Outcome Up-Regulation
ISSN:	1471-2407, 1471-2407
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!